Abstract
Prurit (itchy skin) is a common symptom accompanying chronic cholestasis. The pathogenesis of pruritus in cholestatic diseases is not well understood. It may include a specific neural pathway regulated by substances that can cause skin itching, such as bile acids, opioids, serotonin and lysophosphatidic acid. In exceptional cases, itch refractory to therapy may lead to the need for invasive therapy, including liver transplantation. While the therapeutic management of cholestatic pruritus is well known in adults, children do not agree on the difficulty of conducting controlled clinical trials. The strategy to combat cholestatic pruritus in children is currently based on several areas of specific therapy, which should be associated with skin care and non-specific treatment of cholestasis, including ursodeoxycholic acid. Prurit should be evaluated during treatment as objectively as possible. The first line of treatment for cholestatic pruritus is rifampicin. Second-line therapy is discussed in each case. In the most severe cases, invasive treatments may be suggested. The aim of this work was to review the pathophysiological mechanisms associated with cholestatic pruritus in children and suggest potential therapeutic methods.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.